Venkataraghavan Sourirajan
About Venkataraghavan Sourirajan
Data last updated:
Venkataraghavan Sourirajan was a Director at Grandix Global Pharma Private Limited (2017–2024) and Director at Olympus Therapeutics Private Limited (2015–2023). The companies operate in Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Grandix Global Pharma Private Limited U51909TN2017PTC116820 | Director | 29 May 2017 | 2017 | Active | |
 Olympus Therapeutics Private Limited U24290TN2015PTC101114 | Director | 24 Jun 2015 | 2015 | ₹16.90 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Venkataraghavan Sourirajan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venkataraghavan Sourirajan
Venkataraghavan Sourirajan was first appointed on 24 Jun 2015 as Director at Olympus Therapeutics Private Limited. The most recent appointment on record is 29 May 2017 at Grandix Global Pharma Private Limited.
Venkataraghavan Sourirajan held 2 earlier board appointments: Grandix Global Pharma Private Limited (Director, 29 May 2017 to 01 Apr 2024); Olympus Therapeutics Private Limited (Director, 24 Jun 2015 to 03 Feb 2023).